Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.43 | GERP -3.7 |
| Overall | ||
| CADD | 0.472 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 97.1% | 1 |
| Middle Easterngrpmax | 87.2% | 1 |
| African / African-American | 87.1% | 1 |
| Ashkenazi Jewishnot grpmax-eligible | 86.3% | 1 |
| European (non-Finnish) | 84.5% | 1 |
| Remaining individualsnot grpmax-eligible | 80.9% | 1 |
| Finnishnot grpmax-eligible | 79% | 1 |
| Admixed American | 68.3% | 1 |
| South Asian | 64.7% | 2 |
| East Asian | 49.8% | 2 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- HBB
- Protein
- p.His3=
- Coding
- c.9T>C
- MANE Select
- NM_000518
- dbSNP
- rs713040
- Type
- single nucleotide variant
- Location
- chr11:5227013 (GRCh38)
- Gene constraint
- LOEUF 1.964 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 97.09 · 350 PDB
- Residue 3
- an α-helix; the globin domain; a UniProt-annotated variant site (in graz); a UniProt-annotated variant site (in okayama; o(2) affinity up); a UniProt-annotated variant site (in deer lodge; o(2) affinity up); a UniProt-annotated variant site (in fukuoka); a binding site
Disease context
METHEMOGLOBINEMIA, BETA TYPE — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: Heinz body anemiadominant beta-thalassemiasickle cell diseasealpha thalassemia spectrumbeta-thalassemia HBB/LCRBbeta thalassemiahereditary persistence of fetal hemoglobinmalaria, susceptibility toerythrocytosis, familial, 6
Similar variants
- HBB p.His3fs Pathogenic/Likely pathogenic ★★ same residue
- HBB p.His3_Pro6delinsProGluValLysSerAlaTer Pathogenic same residue
- HBB p.His3Arg Conflicting classifications of pathogenicity ★ ⚠ same residue
- HBB p.His3Pro Uncertain significance ★ ⚠ same residue
- HBB p.His3Gln Likely benign ★ same residue
- HBB c.316-146T>G Pathogenic ★★★ same condition
- HBB c.316-197C>T Pathogenic ★★★ same condition
- HBB c.92+5G>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hbb-p-his3 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown